ASTRO APEx® and RO-ILS™ are applicable to medical malpractice in radiation oncology

Nicholas G. Zaorsky, Anthony G. Ricco, Thomas M. Churilla, Eric M. Horwitz, Robert B. Den

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations


Aim: To analyze malpractice trials in radiation oncology and assess how ASTRO APEx® and RO-ILS™ apply to such cases. Methods: The Westlaw database was reviewed using PICOS/PRISMA methods. Fisher's exact and Mann-Whitney U tests were used to find factors associated with outcomes. Results: Of 34 cases identified, external beam was used in 26 (77%). The most common factors behind malpractice were excessive toxicity (80%) and lack of informed consent (66%). ASTRO APEx pillars and ROI-LS had applicability to all but one case. Factors favoring the defendant included statute of limitations (odds ratio: 8.1; 95% CI: 1.3-50); those favoring the plaintiff included patient death (odds ratio: 0.7; 95% CI: 0.54-0.94). Conclusion: APEx and RO-ILS are applicable to malpractice trials in radiation oncology.

Original languageEnglish (US)
Pages (from-to)2643-2657
Number of pages15
JournalFuture Oncology
Issue number22
StatePublished - Nov 2016

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research


Dive into the research topics of 'ASTRO APEx® and RO-ILS™ are applicable to medical malpractice in radiation oncology'. Together they form a unique fingerprint.

Cite this